Upgrade to SI Premium - Free Trial

Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)

June 17, 2026 6:22 AM
Needham analyst Michael Matson reiterated a Buy rating and $101.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented: "MDT's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments